RISK-FACTORS FOR MELANOMA INCIDENCE IN PROSPECTIVE FOLLOW-UP - THE IMPORTANCE OF ATYPICAL (DYSPLASTIC) NEVI

被引:56
作者
SCHNEIDER, JS
MOORE, DH
SAGEBIEL, RW
机构
[1] LAWRENCE LIVERMORE NATL LAB,BIOL & BIOTECHNOL RES PROGRAM,LIVERMORE,CA
[2] UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA
[3] UNIV CALIF SAN FRANCISCO,DEPT DERMATOL,SAN FRANCISCO,CA 94143
关键词
D O I
10.1001/archderm.130.8.1002
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and Design: Assessment of melanoma risk factors can help identify individuals at greatest risk for melanoma. Previous studies were retrospective case-control or prospective without control groups. A prospective group of 3889 employees without previous melanoma or family history of multiple melanoma at the Lawrence Livermore (Calif) National Laboratory were examined as part of a melanoma screening program. Their subsequent incidence of melanoma in relationship to potential melanoma risk factors, which were recorded at the first examination, was determined. Results: Nine invasive melanomas developed after initial examination among the studied population over an 8-year period with an average follow-up of 5 years. The presence of an easily recognized pattern of definite clinically atypical (dysplastic) nevi was present in 7% of employees and was associated with a cumulative melanoma risk of 1.9%. It was the strongest risk factor, with a relative risk of 47 compared with the 0.04% cumulative melanoma risk in the 64% of employees with no atypical (dysplastic) moles (chi(2) for equal risk, P=7 X 10(-8)). Significant, but less marked associations with melanoma risk were found for the total number of moles and for a history of many moles in other family members, with a maximal relative risk of 11.6 and 10.4, respectively. Conclusion: A small subgroup of the population with easily recognizable definite atypical (dysplastic) nevi have a marked increased risk of melanoma. Smaller significant melanoma risks were found for a total number of moles and a family history of many moles.
引用
收藏
页码:1002 / 1007
页数:6
相关论文
共 27 条
[11]  
2-J
[12]   NUMBER OF MELANOCYTIC NEVI AS A MAJOR RISK FACTOR FOR MALIGNANT-MELANOMA [J].
HOLLY, EA ;
KELLY, JW ;
SHPALL, SN ;
CHIU, SH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 17 (03) :459-468
[13]  
HOLMAN CDJ, 1984, JNCI-J NATL CANCER I, V72, P257
[14]   CLINICAL-DIAGNOSIS OF DYSPLASTIC MELANOCYTIC NEVI - A CLINICOPATHOLOGICAL CORRELATION [J].
KELLY, JW ;
CRUTCHER, WA ;
SAGEBIEL, RW .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 14 (06) :1044-1052
[15]   MEDICAL PROGRESS - CUTANEOUS MELANOMA [J].
KOH, HK .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :171-182
[16]  
MOORE D, 1990, LANCET, V336, P1523
[17]   THE DANISH CASE-CONTROL STUDY OF CUTANEOUS MALIGNANT-MELANOMA .1. IMPORTANCE OF HOST FACTORS [J].
OSTERLIND, A ;
TUCKER, MA ;
HOUJENSEN, K ;
STONE, BJ ;
ENGHOLM, G ;
JENSEN, OM .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (02) :200-206
[19]  
REYNOLDS P, 1982, AM J EPIDEMIOL, V179, P570
[20]  
RIGEL DS, 1989, CANCER, V63, P386, DOI 10.1002/1097-0142(19890115)63:2<386::AID-CNCR2820630231>3.0.CO